Trademarkia Logo

Australia

AU$
Trademark Search
AKERO

View On IPO.GOV.AU

AKERO
Protected: Registered/protected

Last updated on 15 Jul 2022

Owner Info

Akero Therapeutics, Inc.

601 Gateway Boulevard, Suite 350

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

2250027 filed on 6 Dec 2021

Correspondent

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP

233 S Wacker Drive,,

6300 Willis Tower,

UNITED STATES OF AMERICA

AKERO

Classification Information

Class [005]
Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune Read More

Class [042]
Research and development of pharmaceuticals; clinical research in the field of pharmaceuticals.

Mark Details

Serial Number

2250027

Registered On

6 Dec 2021

Renewal On

6 Dec 2031

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
15th Jul 2022International Registration in Australia Protected correspondence sent
14th Jul 2022IP Right Registration Published
14th Jul 2022Status change to Registered/Protected
7th May 2022Application Accepted correspondence sent
7th May 2022IP Right has been Examined
7th May 2022IP Right Acceptance Published
31st Mar 2022Status change to Accepted
23rd Feb 2022Awaiting examination
17th Feb 2022IP Right Filed Published
17th Feb 2022Status change to Published